| P50 | author | Luc Van Kaer | Q37839914 |
| P2093 | author name string | Avneesh K Singh | |
| | Michael T Wilson | |
| P2860 | cites work | CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major | Q43414997 |
| | Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice | Q43612832 |
| | A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells | Q43756252 |
| | Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver | Q45734530 |
| | Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. | Q52176215 |
| | Immune suppression and skin cancer development: regulation by NKT cells. | Q53400482 |
| | Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. | Q53987554 |
| | Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide | Q63363334 |
| | The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice | Q63363340 |
| | Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide | Q63363342 |
| | Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12 | Q63363350 |
| | The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes | Q63363354 |
| | Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi | Q73112858 |
| | NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway | Q73256881 |
| | NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen | Q73586934 |
| | Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 |
| | Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice | Q73977788 |
| | Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes | Q74455329 |
| | Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus | Q104971186 |
| | CD1d and natural T cells: how their properties jump-start the immune system | Q24291160 |
| | Autoreactivity by design: innate B and T lymphocytes | Q28208367 |
| | CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 |
| | Functional diversity of helper T lymphocytes | Q29619415 |
| | Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis | Q33552034 |
| | Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. | Q33713269 |
| | Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets | Q33950117 |
| | NKT cells: facts, functions and fallacies. | Q34091324 |
| | During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein | Q34115997 |
| | The instructive role of innate immunity in the acquired immune response | Q34375203 |
| | Requirement for natural killer T (NKT) cells in the induction of allograft tolerance | Q34475968 |
| | Involvement of decidual Valpha14 NKT cells in abortion | Q34976570 |
| | Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. | Q35675358 |
| | Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells | Q36096376 |
| | Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse | Q36235501 |
| | Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls | Q36338528 |
| | Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis | Q36367900 |
| | Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction | Q36368324 |
| | Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers | Q36368804 |
| | Natural killer T cell activation inhibits hepatitis B virus replication in vivo. | Q36368956 |
| | CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes | Q36369438 |
| | Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. | Q36369797 |
| | Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis | Q36369830 |
| | Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines | Q36370322 |
| | CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. | Q36375489 |
| | Differential tumor surveillance by natural killer (NK) and NKT cells. | Q36375962 |
| | CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution | Q36404242 |
| | CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells | Q36404272 |
| | Critical contribution of liver natural killer T cells to a murine model of hepatitis | Q36979591 |
| | alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria | Q37229005 |
| | Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 |
| | The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells | Q41815553 |
| | Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells | Q41837371 |
| | Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis | Q42157047 |
| P433 | issue | 5 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 225-231 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Trends in Molecular Medicine | Q15265842 |
| P1476 | title | Immunotherapy with ligands of natural killer T cells | |
| P478 | volume | 8 | |